FT Latin America Healthcare & Life Sciences Summit

International companies are expanding aggressively in Latin America in a bid to tap rising healthcare spending by an expanding middle class. Longer life-expectancy and rising popular expectations are putting long-established publically funded healthcare systems under growing pressure and creating opportunity for private providers as increasing numbers of Latin American's look for private care, either through private insurance or the purchase of healthcare services. Latin America's pharmaceutical industry, meanwhile, is experiencing rapid growth as countries move from a predominance of infectious, poverty-related diseases to lifestyle and ageing-related diseases that require more sophisticated drugs and treatments.

The FT Latin America Healthcare and Life Sciences conference will bring together leading industry experts, thought leaders and government decision markers will answer questions, propose solutions and discuss the future of the healthcare sector throughout the Latin America region. Topics of discussion will include: What is the potential for Latin America to become a significant player in the global market for innovator drugs? Will Latin American countries join the international IP system of challenge it? Where are the major opportunities emerging, and what are governments doing to encourage greater private sector investment?

WHY ATTEND?